US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist
  • 1.410
  • -0.130-8.44%
Trading Jan 7 11:04 ET
100.89MMarket Cap-4.76P/E (TTM)

Citius Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
Total revenue
0
0
0
Operating revenue
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
69.72%20.57M
149.58%12.12M
4.86M
Selling and administrative expenses
98.56%15.65M
451.59%7.88M
--1.43M
-General and administrative expense
98.56%15.65M
451.59%7.88M
--1.43M
Research and development costs
16.14%4.93M
23.71%4.24M
--3.43M
Operating profit
-69.72%-20.57M
-149.58%-12.12M
-4.86M
Net non-operating interest income expense
Other net income (expense)
Income before tax
-69.72%-20.57M
-149.58%-12.12M
-4.86M
Income tax
0.00%576K
0.00%576K
576K
Net income
-66.56%-21.15M
-133.72%-12.7M
-5.43M
Net income continuous Operations
-66.56%-21.15M
-133.72%-12.7M
---5.43M
Minority interest income
Net income attributable to the parent company
-66.56%-21.15M
-133.72%-12.7M
-5.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.56%-21.15M
-133.72%-12.7M
-5.43M
Basic earnings per share
-73.93%-0.31
-133.72%-0.1782
-0.0763
Diluted earnings per share
-73.93%-0.31
-133.72%-0.1782
-0.0763
Dividend per share
Currency Unit
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022
Total revenue 000
Operating revenue --0--0--0
Cost of revenue
Gross profit
Operating expense 69.72%20.57M149.58%12.12M4.86M
Selling and administrative expenses 98.56%15.65M451.59%7.88M--1.43M
-General and administrative expense 98.56%15.65M451.59%7.88M--1.43M
Research and development costs 16.14%4.93M23.71%4.24M--3.43M
Operating profit -69.72%-20.57M-149.58%-12.12M-4.86M
Net non-operating interest income expense
Other net income (expense)
Income before tax -69.72%-20.57M-149.58%-12.12M-4.86M
Income tax 0.00%576K0.00%576K576K
Net income -66.56%-21.15M-133.72%-12.7M-5.43M
Net income continuous Operations -66.56%-21.15M-133.72%-12.7M---5.43M
Minority interest income
Net income attributable to the parent company -66.56%-21.15M-133.72%-12.7M-5.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.56%-21.15M-133.72%-12.7M-5.43M
Basic earnings per share -73.93%-0.31-133.72%-0.1782-0.0763
Diluted earnings per share -73.93%-0.31-133.72%-0.1782-0.0763
Dividend per share
Currency Unit USDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes----
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.